ReviewClinical pharmacokinetics2026

Clinical Pharmacokinetics of Polmacoxib (CG100649): A Tissue-Selective Dual COX-2 and Carbonic Anhydrase I/II Inhibitor.

Marlon C Mallillin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.